ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034)
The purpose of this study is to evaluate the efficacy, safety, and tolerability of gefapixant (MK-7264) in premenopausal female participants with moderate to severe endometriosis-related pain. The primary hypothesis: gefapixant is superior to placebo in reducing the average daily pelvic pain score (cyclic and non-cyclic, combined) during Treatment Cycle 2.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Genomic Maps of Endometrial Tissues of Patients With Endometriosis and Healthy Controls#862509
- The Effect of Dionegest Use on the Frequency of Fibromyalgia in Endometriosis#864278
- Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain#836810
- The Influence of Central Sensitization in Endometriosis Disease#872840
- Use of Rosiglitazone in the Treatment of Endometriosis#1113529
Record · ID 1453551
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive